Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123855532 | 12385553 | 2 | F | 2008 | 20160711 | 20160519 | 20160715 | EXP | US-GLAXOSMITHKLINE-US2016070227 | GLAXOSMITHKLINE | 81.45 | YR | F | Y | 0.00000 | 20160715 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123855532 | 12385553 | 1 | PS | FLOVENT | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | U | 21433 | 1 | DF | BID | ||||||
| 123855532 | 12385553 | 2 | SS | FLOVENT | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 2 PUFF(S), BID | U | 21433 | 2 | DF | BID | ||||||
| 123855532 | 12385553 | 3 | SS | FLOVENT | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | U | 21433 | 1 | DF | BID | ||||||
| 123855532 | 12385553 | 4 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 123855532 | 12385553 | 5 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 123855532 | 12385553 | 6 | C | PRO-AIR (ALBUTEROL SULFATE) | 2 | 0 | |||||||||||||
| 123855532 | 12385553 | 7 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 123855532 | 12385553 | 8 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 123855532 | 12385553 | 9 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 123855532 | 12385553 | 10 | C | CLARITIN | LORATADINE | 1 | 0 | ||||||||||||
| 123855532 | 12385553 | 11 | C | FENOFIBRATE. | FENOFIBRATE | 1 | 0 | ||||||||||||
| 123855532 | 12385553 | 12 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
| 123855532 | 12385553 | 13 | C | ZESTORETIC | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123855532 | 12385553 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123855532 | 12385553 | HO |
| 123855532 | 12385553 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123855532 | 12385553 | Bundle branch block right | |
| 123855532 | 12385553 | Cardiac failure congestive | |
| 123855532 | 12385553 | Chronic obstructive pulmonary disease | |
| 123855532 | 12385553 | Dyspnoea | |
| 123855532 | 12385553 | Essential hypertension | |
| 123855532 | 12385553 | Hyperlipidaemia | |
| 123855532 | 12385553 | Intervertebral disc degeneration | |
| 123855532 | 12385553 | Macular degeneration | |
| 123855532 | 12385553 | Peripheral vascular disorder | |
| 123855532 | 12385553 | Sciatica | |
| 123855532 | 12385553 | Scoliosis | |
| 123855532 | 12385553 | Spinal column stenosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123855532 | 12385553 | 1 | 201512 | 0 | ||
| 123855532 | 12385553 | 2 | 201512 | 201605 | 0 | |
| 123855532 | 12385553 | 3 | 201605 | 0 |